Request for Covid-19 Impact Assessment of this Report
The United States Veterinary Antibiotics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Veterinary Antibiotics market, reaching US$ million by the year 2028. As for the Europe Veterinary Antibiotics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Veterinary Antibiotics players cover Zoetis animal healthcare, Merck, Merial (Animal Health Division Of Sanofi), and Elanco, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Antibiotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tetracyclines
Penicillins
Macrolides
Sulphonamides
Aminoglycosides
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Farm Animals
Companion Animals
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Zoetis animal healthcare
Merck
Merial (Animal Health Division Of Sanofi)
Elanco
Bayer healthcare
Ceva Animal Health, Inc.
Virbac
Boehringer Ingelheim
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Veterinary Antibiotics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Veterinary Antibiotics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Veterinary Antibiotics by Country/Region, 2017, 2022 & 2028
2.2 Veterinary Antibiotics Segment by Type
2.2.1 Tetracyclines
2.2.2 Penicillins
2.2.3 Macrolides
2.2.4 Sulphonamides
2.2.5 Aminoglycosides
2.3 Veterinary Antibiotics Sales by Type
2.3.1 Global Veterinary Antibiotics Sales Market Share by Type (2017-2022)
2.3.2 Global Veterinary Antibiotics Revenue and Market Share by Type (2017-2022)
2.3.3 Global Veterinary Antibiotics Sale Price by Type (2017-2022)
2.4 Veterinary Antibiotics Segment by Application
2.4.1 Farm Animals
2.4.2 Companion Animals
2.5 Veterinary Antibiotics Sales by Application
2.5.1 Global Veterinary Antibiotics Sale Market Share by Application (2017-2022)
2.5.2 Global Veterinary Antibiotics Revenue and Market Share by Application (2017-2022)
2.5.3 Global Veterinary Antibiotics Sale Price by Application (2017-2022)
3 Global Veterinary Antibiotics by Company
3.1 Global Veterinary Antibiotics Breakdown Data by Company
3.1.1 Global Veterinary Antibiotics Annual Sales by Company (2020-2022)
3.1.2 Global Veterinary Antibiotics Sales Market Share by Company (2020-2022)
3.2 Global Veterinary Antibiotics Annual Revenue by Company (2020-2022)
3.2.1 Global Veterinary Antibiotics Revenue by Company (2020-2022)
3.2.2 Global Veterinary Antibiotics Revenue Market Share by Company (2020-2022)
3.3 Global Veterinary Antibiotics Sale Price by Company
3.4 Key Manufacturers Veterinary Antibiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Antibiotics Product Location Distribution
3.4.2 Players Veterinary Antibiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Veterinary Antibiotics by Geographic Region
4.1 World Historic Veterinary Antibiotics Market Size by Geographic Region (2017-2022)
4.1.1 Global Veterinary Antibiotics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Veterinary Antibiotics Annual Revenue by Geographic Region
4.2 World Historic Veterinary Antibiotics Market Size by Country/Region (2017-2022)
4.2.1 Global Veterinary Antibiotics Annual Sales by Country/Region (2017-2022)
4.2.2 Global Veterinary Antibiotics Annual Revenue by Country/Region
4.3 Americas Veterinary Antibiotics Sales Growth
4.4 APAC Veterinary Antibiotics Sales Growth
4.5 Europe Veterinary Antibiotics Sales Growth
4.6 Middle East & Africa Veterinary Antibiotics Sales Growth
5 Americas
5.1 Americas Veterinary Antibiotics Sales by Country
5.1.1 Americas Veterinary Antibiotics Sales by Country (2017-2022)
5.1.2 Americas Veterinary Antibiotics Revenue by Country (2017-2022)
5.2 Americas Veterinary Antibiotics Sales by Type
5.3 Americas Veterinary Antibiotics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Antibiotics Sales by Region
6.1.1 APAC Veterinary Antibiotics Sales by Region (2017-2022)
6.1.2 APAC Veterinary Antibiotics Revenue by Region (2017-2022)
6.2 APAC Veterinary Antibiotics Sales by Type
6.3 APAC Veterinary Antibiotics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Veterinary Antibiotics by Country
7.1.1 Europe Veterinary Antibiotics Sales by Country (2017-2022)
7.1.2 Europe Veterinary Antibiotics Revenue by Country (2017-2022)
7.2 Europe Veterinary Antibiotics Sales by Type
7.3 Europe Veterinary Antibiotics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary Antibiotics by Country
8.1.1 Middle East & Africa Veterinary Antibiotics Sales by Country (2017-2022)
8.1.2 Middle East & Africa Veterinary Antibiotics Revenue by Country (2017-2022)
8.2 Middle East & Africa Veterinary Antibiotics Sales by Type
8.3 Middle East & Africa Veterinary Antibiotics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Antibiotics
10.3 Manufacturing Process Analysis of Veterinary Antibiotics
10.4 Industry Chain Structure of Veterinary Antibiotics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Antibiotics Distributors
11.3 Veterinary Antibiotics Customer
12 World Forecast Review for Veterinary Antibiotics by Geographic Region
12.1 Global Veterinary Antibiotics Market Size Forecast by Region
12.1.1 Global Veterinary Antibiotics Forecast by Region (2023-2028)
12.1.2 Global Veterinary Antibiotics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Antibiotics Forecast by Type
12.7 Global Veterinary Antibiotics Forecast by Application
13 Key Players Analysis
13.1 Zoetis animal healthcare
13.1.1 Zoetis animal healthcare Company Information
13.1.2 Zoetis animal healthcare Veterinary Antibiotics Product Offered
13.1.3 Zoetis animal healthcare Veterinary Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Zoetis animal healthcare Main Business Overview
13.1.5 Zoetis animal healthcare Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Veterinary Antibiotics Product Offered
13.2.3 Merck Veterinary Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Merial (Animal Health Division Of Sanofi)
13.3.1 Merial (Animal Health Division Of Sanofi) Company Information
13.3.2 Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Product Offered
13.3.3 Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merial (Animal Health Division Of Sanofi) Main Business Overview
13.3.5 Merial (Animal Health Division Of Sanofi) Latest Developments
13.4 Elanco
13.4.1 Elanco Company Information
13.4.2 Elanco Veterinary Antibiotics Product Offered
13.4.3 Elanco Veterinary Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Elanco Main Business Overview
13.4.5 Elanco Latest Developments
13.5 Bayer healthcare
13.5.1 Bayer healthcare Company Information
13.5.2 Bayer healthcare Veterinary Antibiotics Product Offered
13.5.3 Bayer healthcare Veterinary Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bayer healthcare Main Business Overview
13.5.5 Bayer healthcare Latest Developments
13.6 Ceva Animal Health, Inc.
13.6.1 Ceva Animal Health, Inc. Company Information
13.6.2 Ceva Animal Health, Inc. Veterinary Antibiotics Product Offered
13.6.3 Ceva Animal Health, Inc. Veterinary Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ceva Animal Health, Inc. Main Business Overview
13.6.5 Ceva Animal Health, Inc. Latest Developments
13.7 Virbac
13.7.1 Virbac Company Information
13.7.2 Virbac Veterinary Antibiotics Product Offered
13.7.3 Virbac Veterinary Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Virbac Main Business Overview
13.7.5 Virbac Latest Developments
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Information
13.8.2 Boehringer Ingelheim Veterinary Antibiotics Product Offered
13.8.3 Boehringer Ingelheim Veterinary Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Boehringer Ingelheim Main Business Overview
13.8.5 Boehringer Ingelheim Latest Developments
14 Research Findings and Conclusion
Table 1. Veterinary Antibiotics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Veterinary Antibiotics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tetracyclines
Table 4. Major Players of Penicillins
Table 5. Major Players of Macrolides
Table 6. Major Players of Sulphonamides
Table 7. Major Players of Aminoglycosides
Table 8. Global Veterinary Antibiotics Sales by Type (2017-2022) & (K Units)
Table 9. Global Veterinary Antibiotics Sales Market Share by Type (2017-2022)
Table 10. Global Veterinary Antibiotics Revenue by Type (2017-2022) & ($ million)
Table 11. Global Veterinary Antibiotics Revenue Market Share by Type (2017-2022)
Table 12. Global Veterinary Antibiotics Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Veterinary Antibiotics Sales by Application (2017-2022) & (K Units)
Table 14. Global Veterinary Antibiotics Sales Market Share by Application (2017-2022)
Table 15. Global Veterinary Antibiotics Revenue by Application (2017-2022)
Table 16. Global Veterinary Antibiotics Revenue Market Share by Application (2017-2022)
Table 17. Global Veterinary Antibiotics Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Veterinary Antibiotics Sales by Company (2020-2022) & (K Units)
Table 19. Global Veterinary Antibiotics Sales Market Share by Company (2020-2022)
Table 20. Global Veterinary Antibiotics Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Veterinary Antibiotics Revenue Market Share by Company (2020-2022)
Table 22. Global Veterinary Antibiotics Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Veterinary Antibiotics Producing Area Distribution and Sales Area
Table 24. Players Veterinary Antibiotics Products Offered
Table 25. Veterinary Antibiotics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Veterinary Antibiotics Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Veterinary Antibiotics Sales Market Share Geographic Region (2017-2022)
Table 30. Global Veterinary Antibiotics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Veterinary Antibiotics Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Veterinary Antibiotics Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Veterinary Antibiotics Sales Market Share by Country/Region (2017-2022)
Table 34. Global Veterinary Antibiotics Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Veterinary Antibiotics Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Veterinary Antibiotics Sales by Country (2017-2022) & (K Units)
Table 37. Americas Veterinary Antibiotics Sales Market Share by Country (2017-2022)
Table 38. Americas Veterinary Antibiotics Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Veterinary Antibiotics Revenue Market Share by Country (2017-2022)
Table 40. Americas Veterinary Antibiotics Sales by Type (2017-2022) & (K Units)
Table 41. Americas Veterinary Antibiotics Sales Market Share by Type (2017-2022)
Table 42. Americas Veterinary Antibiotics Sales by Application (2017-2022) & (K Units)
Table 43. Americas Veterinary Antibiotics Sales Market Share by Application (2017-2022)
Table 44. APAC Veterinary Antibiotics Sales by Region (2017-2022) & (K Units)
Table 45. APAC Veterinary Antibiotics Sales Market Share by Region (2017-2022)
Table 46. APAC Veterinary Antibiotics Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Veterinary Antibiotics Revenue Market Share by Region (2017-2022)
Table 48. APAC Veterinary Antibiotics Sales by Type (2017-2022) & (K Units)
Table 49. APAC Veterinary Antibiotics Sales Market Share by Type (2017-2022)
Table 50. APAC Veterinary Antibiotics Sales by Application (2017-2022) & (K Units)
Table 51. APAC Veterinary Antibiotics Sales Market Share by Application (2017-2022)
Table 52. Europe Veterinary Antibiotics Sales by Country (2017-2022) & (K Units)
Table 53. Europe Veterinary Antibiotics Sales Market Share by Country (2017-2022)
Table 54. Europe Veterinary Antibiotics Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Veterinary Antibiotics Revenue Market Share by Country (2017-2022)
Table 56. Europe Veterinary Antibiotics Sales by Type (2017-2022) & (K Units)
Table 57. Europe Veterinary Antibiotics Sales Market Share by Type (2017-2022)
Table 58. Europe Veterinary Antibiotics Sales by Application (2017-2022) & (K Units)
Table 59. Europe Veterinary Antibiotics Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Veterinary Antibiotics Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Veterinary Antibiotics Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Veterinary Antibiotics Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Veterinary Antibiotics Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Veterinary Antibiotics Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Veterinary Antibiotics Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Veterinary Antibiotics Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Veterinary Antibiotics Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Veterinary Antibiotics
Table 69. Key Market Challenges & Risks of Veterinary Antibiotics
Table 70. Key Industry Trends of Veterinary Antibiotics
Table 71. Veterinary Antibiotics Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Veterinary Antibiotics Distributors List
Table 74. Veterinary Antibiotics Customer List
Table 75. Global Veterinary Antibiotics Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Veterinary Antibiotics Sales Market Forecast by Region
Table 77. Global Veterinary Antibiotics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Veterinary Antibiotics Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Veterinary Antibiotics Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Veterinary Antibiotics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Veterinary Antibiotics Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Veterinary Antibiotics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Veterinary Antibiotics Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Veterinary Antibiotics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Veterinary Antibiotics Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Veterinary Antibiotics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Veterinary Antibiotics Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Veterinary Antibiotics Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Veterinary Antibiotics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Veterinary Antibiotics Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Veterinary Antibiotics Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Veterinary Antibiotics Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Veterinary Antibiotics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Veterinary Antibiotics Revenue Market Share Forecast by Application (2023-2028)
Table 95. Zoetis animal healthcare Basic Information, Veterinary Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 96. Zoetis animal healthcare Veterinary Antibiotics Product Offered
Table 97. Zoetis animal healthcare Veterinary Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Zoetis animal healthcare Main Business
Table 99. Zoetis animal healthcare Latest Developments
Table 100. Merck Basic Information, Veterinary Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 101. Merck Veterinary Antibiotics Product Offered
Table 102. Merck Veterinary Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Merck Main Business
Table 104. Merck Latest Developments
Table 105. Merial (Animal Health Division Of Sanofi) Basic Information, Veterinary Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 106. Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Product Offered
Table 107. Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Merial (Animal Health Division Of Sanofi) Main Business
Table 109. Merial (Animal Health Division Of Sanofi) Latest Developments
Table 110. Elanco Basic Information, Veterinary Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 111. Elanco Veterinary Antibiotics Product Offered
Table 112. Elanco Veterinary Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Elanco Main Business
Table 114. Elanco Latest Developments
Table 115. Bayer healthcare Basic Information, Veterinary Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 116. Bayer healthcare Veterinary Antibiotics Product Offered
Table 117. Bayer healthcare Veterinary Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Bayer healthcare Main Business
Table 119. Bayer healthcare Latest Developments
Table 120. Ceva Animal Health, Inc. Basic Information, Veterinary Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 121. Ceva Animal Health, Inc. Veterinary Antibiotics Product Offered
Table 122. Ceva Animal Health, Inc. Veterinary Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Ceva Animal Health, Inc. Main Business
Table 124. Ceva Animal Health, Inc. Latest Developments
Table 125. Virbac Basic Information, Veterinary Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 126. Virbac Veterinary Antibiotics Product Offered
Table 127. Virbac Veterinary Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Virbac Main Business
Table 129. Virbac Latest Developments
Table 130. Boehringer Ingelheim Basic Information, Veterinary Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 131. Boehringer Ingelheim Veterinary Antibiotics Product Offered
Table 132. Boehringer Ingelheim Veterinary Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Boehringer Ingelheim Main Business
Table 134. Boehringer Ingelheim Latest Developments
List of Figures
Figure 1. Picture of Veterinary Antibiotics
Figure 2. Veterinary Antibiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Antibiotics Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Veterinary Antibiotics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Veterinary Antibiotics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tetracyclines
Figure 10. Product Picture of Penicillins
Figure 11. Product Picture of Macrolides
Figure 12. Product Picture of Sulphonamides
Figure 13. Product Picture of Aminoglycosides
Figure 14. Global Veterinary Antibiotics Sales Market Share by Type in 2021
Figure 15. Global Veterinary Antibiotics Revenue Market Share by Type (2017-2022)
Figure 16. Veterinary Antibiotics Consumed in Farm Animals
Figure 17. Global Veterinary Antibiotics Market: Farm Animals (2017-2022) & (K Units)
Figure 18. Veterinary Antibiotics Consumed in Companion Animals
Figure 19. Global Veterinary Antibiotics Market: Companion Animals (2017-2022) & (K Units)
Figure 20. Global Veterinary Antibiotics Sales Market Share by Application (2017-2022)
Figure 21. Global Veterinary Antibiotics Revenue Market Share by Application in 2021
Figure 22. Veterinary Antibiotics Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Veterinary Antibiotics Revenue Market Share by Company in 2021
Figure 24. Global Veterinary Antibiotics Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Veterinary Antibiotics Revenue Market Share by Geographic Region in 2021
Figure 26. Global Veterinary Antibiotics Sales Market Share by Region (2017-2022)
Figure 27. Global Veterinary Antibiotics Revenue Market Share by Country/Region in 2021
Figure 28. Americas Veterinary Antibiotics Sales 2017-2022 (K Units)
Figure 29. Americas Veterinary Antibiotics Revenue 2017-2022 ($ Millions)
Figure 30. APAC Veterinary Antibiotics Sales 2017-2022 (K Units)
Figure 31. APAC Veterinary Antibiotics Revenue 2017-2022 ($ Millions)
Figure 32. Europe Veterinary Antibiotics Sales 2017-2022 (K Units)
Figure 33. Europe Veterinary Antibiotics Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Veterinary Antibiotics Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Veterinary Antibiotics Revenue 2017-2022 ($ Millions)
Figure 36. Americas Veterinary Antibiotics Sales Market Share by Country in 2021
Figure 37. Americas Veterinary Antibiotics Revenue Market Share by Country in 2021
Figure 38. United States Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Veterinary Antibiotics Sales Market Share by Region in 2021
Figure 43. APAC Veterinary Antibiotics Revenue Market Share by Regions in 2021
Figure 44. China Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Veterinary Antibiotics Sales Market Share by Country in 2021
Figure 51. Europe Veterinary Antibiotics Revenue Market Share by Country in 2021
Figure 52. Germany Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Veterinary Antibiotics Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Veterinary Antibiotics Revenue Market Share by Country in 2021
Figure 59. Egypt Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Veterinary Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Veterinary Antibiotics in 2021
Figure 65. Manufacturing Process Analysis of Veterinary Antibiotics
Figure 66. Industry Chain Structure of Veterinary Antibiotics
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...